COVID-19 vaccination rate and protection attitudes can determine the best prioritisation strategy to reduce fatalities

Author:

Rodríguez JorgeORCID,Patón Mauricio,Acuña Juan M

Abstract

AbstractBackgroundThe unprecedented rapid development of vaccines against the SARS-CoV-2 virus creates in itself a new challenge for governments and health authorities: the effective vaccination of large numbers of people in a short time and, possibly, with shortage of vaccine doses. To whom vaccinate first and in what sequence, if any at all, to avoid the most fatalities remains an open question.MethodsA compartmental model considering age-related groups was developed to evaluate and compare vaccine distribution strategies in terms of the total avoidable fatalities. Population groups are established based on relevant differences in mortality (due to e.g. their age) and risk-related traits (such as their behaviour and number of daily person-to-person interactions). Vaccination distribution strategies were evaluated for different vaccine effectiveness levels, population coverage and vaccination rate using data mainly from Spain.FindingsOur results show that, if children could also be included in the vaccination, a rollout by priority to groups with the highest number of daily person-to-person interactions can achieve large reductions in total fatalities. This is due to the importance of the avoided subsequent infections inflicted on the rest of the population by highly interactive individuals. If children are excluded from the vaccination, the differences between priority strategies become smaller and appear highly depending on rollout rate, coverage and the levels of self-protection and awareness exercised by the population.InterpretationThese results are in possible contradiction with several published plans for COVID-19 vaccination and highlight the importance of conducting an open comprehensive and thorough analysis of this problem leaving behind possible preconceptions.

Publisher

Cold Spring Harbor Laboratory

Reference51 articles.

1. JHCRC. John Hopkins - Coronavirus Resource Center [Internet]. Johns Hopkins Coronavirus Resource Center. [cited 2020 Nov 4]. Available from: https://coronavirus.jhu.edu/map.html

2. Dong E , Du H , Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases [Internet]. 2020 Feb 19 [cited 2020 Apr 29];0(0). Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30120-1/abstract

3. Lipsitch M , Dean NE . Understanding COVID-19 vaccine efficacy. Science [Internet]. 2020 Oct 21 [cited 2020 Oct 27]; Available from: https://science.sciencemag.org/content/early/2020/10/21/science.abe5938

4. The complexity and cost of vaccine manufacturing – An overview;Vaccine,2017

5. COVID-19 vaccine development pipeline gears up;The Lancet,2020

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3